Back to Journals » Biologics: Targets and Therapy » Volume 2 » Issue 3

Biologics: Targets and Therapy


Archive: Volume 2, 2008


IgG from patients with systemic sclerosis bind to DNA antitopoisomerase 1 in normal human fibroblasts extracts

Mathieu C Tamby, Amélie Servettaz, Nicolas Tamas, Joseph Reinbolt, Frédéric Caux, et al

Biologics: Targets and Therapy 2008, 2:583-591

Published Date: 12 September 2008

The antidiabetic effects of a dry powder of dietary vegetable and fruit mixtures in diabetic db/db mice

Chung-Man Yeung, Yi Tan, Sidney Tam, Liwei Lu, King-Hung Ko, et al

Biologics: Targets and Therapy 2008, 2:571-576

Published Date: 12 September 2008

Analysis and variability of TGFβ measurements in cancer patients with skeletal metastases

Peter J O’Brien, Rajeev Ramanathan, Jonathan M Yingling, Jose Baselga, Mace L Rothenberg, et al

Biologics: Targets and Therapy 2008, 2:563-569

Published Date: 12 September 2008

Randomized phase II clinical trial of chemo-immunotherapy in advanced nonsmall cell lung cancer

Eduardo Lasalvia-Prisco, Emilio Garcia-Giralt, Jesús Vázquez, Marta Aghazarian, Eduardo Lasalvia-Galante, et al

Biologics: Targets and Therapy 2008, 2:555-561

Published Date: 12 September 2008

Functional and gene expression analysis of hTERT overexpressed endothelial cells

Haruna Takano, Satoshi Murasawa, Takayuki Asahara

Biologics: Targets and Therapy 2008, 2:547-554

Published Date: 12 September 2008

Novel targets for immunotherapy in glomerulonephritis

Mary H Foster

Biologics: Targets and Therapy 2008, 2:531-545

Published Date: 12 September 2008

Targeted therapies in the management of renal cell carcinoma: role of bevacizumab

Bernard Escudier, Jan Cosaert, Sangeeta Jethwa

Biologics: Targets and Therapy 2008, 2:517-530

Published Date: 12 September 2008

Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancer

Shannon Puhalla, Adam Brufsky

Biologics: Targets and Therapy 2008, 2:505-515

Published Date: 12 September 2008

New treatment options in the management of IBD – focus on colony stimulating factors

Josué Barahona-Garrido, Jesús K Yamamoto-Furusho

Biologics: Targets and Therapy 2008, 2:501-504

Published Date: 12 September 2008

Tipifarnib in the treatment of newly diagnosed acute myelogenous leukemia

Judith E Karp, Jeffrey E Lancet

Biologics: Targets and Therapy 2008, 2:491-500

Published Date: 12 September 2008

Therapeutic options in the management of acromegaly: focus on lanreotide Autogel®

Ferdinand Roelfsema, Nienke R Biermasz, Alberto M Pereira, Johannes A Romijn

Biologics: Targets and Therapy 2008, 2:463-479

Published Date: 12 September 2008

Evolving therapies in the treatment of hepatocellular carcinoma

Hans Christian Spangenberg, Robert Thimme, Hubert E Blum

Biologics: Targets and Therapy 2008, 2:453-462

Published Date: 12 September 2008

Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action

Lina Nordquist, Fredrik Palm, Bradley T Andresen

Biologics: Targets and Therapy 2008, 2:441-452

Published Date: 12 September 2008

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants

Asunción Mejías, Octavio Ramilo

Biologics: Targets and Therapy 2008, 2:433-439

Published Date: 12 September 2008

Advances in the treatment of monoclonal gammopaties: The emerging role of targeted therapy in plasma cell dyscrasias

Aldo M Roccaro, Irene M Ghobrial, Simona Blotta, Steven P Treon, Michele Malagola, et al

Biologics: Targets and Therapy 2008, 2:419-431

Published Date: 12 September 2008

Top-down or bottom-up: Contrasting perspectives on psychiatric diagnoses

Willem MA Verhoeven, Siegfried Tuinier, Ineke van der Burgt

Biologics: Targets and Therapy 2008, 2:409-417

Published Date: 12 September 2008

Emerging hematological targets and therapy for cardiovascular disease: From bench to bedside

Ana Villegas, Fernando A Gonzalez, Leopoldo Llorente, Santiago Redondo

Biologics: Targets and Therapy 2008, 2:397-407

Published Date: 12 September 2008

The role of B cells in systemic sclerosis

Marina D Kraaij, Jacob M van Laar

Biologics: Targets and Therapy 2008, 2:389-395

Published Date: 12 September 2008

Infliximab in ulcerative colitis

Avi Levin, Oren Shibolet

Biologics: Targets and Therapy 2008, 2:379-388

Published Date: 12 September 2008

Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells

Satya Prakash, Aleksandra Malgorzata Urbanska

Biologics: Targets and Therapy 2008, 2:355-378

Published Date: 12 September 2008

Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures

Neil Ghodadra, Kern Singh

Biologics: Targets and Therapy 2008, 2:345-354

Published Date: 12 September 2008